Negative-pressure Wound Therapy (NPWT) Market Share

Regionally, the negative-pressure wound therapy (NPWT) market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is predicted to hold largest revenue share by 2036, backed by rise in occurrence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers with the increase in geriatric population, increasing healthcare expenditure, and expanding research and development (R&D) activities in the region. According to the Centers for Medicare & Medicaid Services, national health expenditure is expected to rise by 5.1% per year from 2021 to 2030, reaching nearly USD 6.8 trillion.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of negative-pressure wound therapy is estimated at USD 2.69 billion.

Negative-pressure Wound Therapy (NPWT) Market size was valued at USD 2.56 billion in 2024 and is likely to reach USD 5.8 billion by 2037, registering around 6.5% CAGR during the forecast period i.e., between 2024-2036. Increasing cases of burns, rise in diabetes cases, expansion of geriatric population, and growing prevalence of post-surgical wounds will propel the market growth.

North America is predicted to hold largest revenue share by 2036, backed by rise in occurrence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers with the increase in geriatric population, increasing healthcare expenditure, and expanding research and development (R&D) activities in the region.

The major players in the market are Smith & Nephew, PLC, Acelity L.P., Inc., Cardinal Health, DeRoyal Industries Inc., Genadyne Biotechnologies, Inc., Medela, LLC., ConvaTec, Inc., ATMOS MedizinTechnik, GmbH & Co. KG, and others.

Negative-pressure Wound Therapy (NPWT) Market Share